Therefore, a consultation with a doctor is necessary to explore this option
GIP/GLP-1 co-agonists, developed by merging the respective peptide sequences, potently lower body weight in rodents and humans 27,28
The first few weeks on GLP-1 medications can feel different for everyone
A small protein snack every few hours beats one attempted meal
Once the decision to switch is made, an individualised approach is recommended, based on considerations that include reimbursement requirements, treatment duration with (and dose of) previous GLP1RA, the patient's experience initiating the prior GLP1RA, any concomitant treatment and clinical characteristics
The FDA does not review or approve any compounded medications for safety or effectiveness